Literature DB >> 20388773

Sleeping beauty-mediated somatic mutagenesis implicates CSF1 in the formation of high-grade astrocytomas.

Aaron M Bender1, Lara S Collier, Fausto J Rodriguez, Christina Tieu, Jon D Larson, Chandralekha Halder, Eric Mahlum, Thomas M Kollmeyer, Keiko Akagi, Gobinda Sarkar, David A Largaespada, Robert B Jenkins.   

Abstract

The Sleeping Beauty (SB) transposon system has been used as an insertional mutagenesis tool to identify novel cancer genes. To identify glioma-associated genes, we evaluated tumor formation in the brain tissue from 117 transgenic mice that had undergone constitutive SB-mediated transposition. Upon analysis, 21 samples (18%) contained neoplastic tissue with features of high-grade astrocytomas. These tumors expressed glial markers and were histologically similar to human glioma. Genomic DNA from SB-induced astrocytoma tissue was extracted and transposon insertion sites were identified. Insertions in the growth factor gene Csf1 were found in 13 of the 21 tumors (62%), clustered in introns 5 and 8. Using reverse transcription-PCR, we documented increased Csf1 RNAs in tumor versus adjacent normal tissue, with the identification of transposon-terminated Csf1 mRNAs in astrocytomas with SB insertions in intron 8. Analysis of human glioblastomas revealed increased levels of Csf1 RNA and protein. Together, these results indicate that SB-insertional mutagenesis can identify high-grade astrocytoma-associated genes and they imply an important role for CSF1 in the development of these tumors. (c)2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20388773      PMCID: PMC2862088          DOI: 10.1158/0008-5472.CAN-09-4674

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  44 in total

1.  Cancer predisposition caused by elevated mitotic recombination in Bloom mice.

Authors:  G Luo; I M Santoro; L D McDaniel; I Nishijima; M Mills; H Youssoufian; H Vogel; R A Schultz; A Bradley
Journal:  Nat Genet       Date:  2000-12       Impact factor: 38.330

2.  Elevated expression of the oncogene c-fms and its ligand, the macrophage colony-stimulating factor-1, in cervical cancer and the role of transforming growth factor-beta1 in inducing c-fms expression.

Authors:  Nameer Kirma; Luciano S Hammes; Ya-Guang Liu; Hareesh B Nair; Philip T Valente; Shantha Kumar; Lisa C Flowers; Rajeshwar Rao Tekmal
Journal:  Cancer Res       Date:  2007-03-01       Impact factor: 12.701

3.  A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma.

Authors:  Vincent W Keng; Augusto Villanueva; Derek Y Chiang; Adam J Dupuy; Barbara J Ryan; Ilze Matise; Kevin A T Silverstein; Aaron Sarver; Timothy K Starr; Keiko Akagi; Lino Tessarollo; Lara S Collier; Scott Powers; Scott W Lowe; Nancy A Jenkins; Neal G Copeland; Josep M Llovet; David A Largaespada
Journal:  Nat Biotechnol       Date:  2009-02-22       Impact factor: 54.908

4.  The multifunctional protein glyceraldehyde-3-phosphate dehydrogenase is both regulated and controls colony-stimulating factor-1 messenger RNA stability in ovarian cancer.

Authors:  Yi Zhou; Xiaofang Yi; Jha'nae B Stoffer; Nathalie Bonafe; Maureen Gilmore-Hebert; Jessica McAlpine; Setsuko K Chambers
Journal:  Mol Cancer Res       Date:  2008-08       Impact factor: 5.852

Review 5.  Macrophage colony stimulating factor: not just for macrophages anymore! A gateway into complex biologies.

Authors:  Thomas G Douglass; Lara Driggers; Jian Gang Zhang; Neil Hoa; Christina Delgado; Christopher C Williams; Qinhong Dan; Ramon Sanchez; Edward W B Jeffes; H Terry Wepsic; Michael P Myers; Kirston Koths; Martin R Jadus
Journal:  Int Immunopharmacol       Date:  2008-06-02       Impact factor: 4.932

6.  Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal.

Authors:  Jakub Godlewski; Michal O Nowicki; Agnieszka Bronisz; Shanté Williams; Akihiro Otsuki; Gerard Nuovo; Abhik Raychaudhury; Herbert B Newton; E Antonio Chiocca; Sean Lawler
Journal:  Cancer Res       Date:  2008-11-15       Impact factor: 12.701

7.  An integrated genomic analysis of human glioblastoma multiforme.

Authors:  D Williams Parsons; Siân Jones; Xiaosong Zhang; Jimmy Cheng-Ho Lin; Rebecca J Leary; Philipp Angenendt; Parminder Mankoo; Hannah Carter; I-Mei Siu; Gary L Gallia; Alessandro Olivi; Roger McLendon; B Ahmed Rasheed; Stephen Keir; Tatiana Nikolskaya; Yuri Nikolsky; Dana A Busam; Hanna Tekleab; Luis A Diaz; James Hartigan; Doug R Smith; Robert L Strausberg; Suely Kazue Nagahashi Marie; Sueli Mieko Oba Shinjo; Hai Yan; Gregory J Riggins; Darell D Bigner; Rachel Karchin; Nick Papadopoulos; Giovanni Parmigiani; Bert Vogelstein; Victor E Velculescu; Kenneth W Kinzler
Journal:  Science       Date:  2008-09-04       Impact factor: 47.728

8.  Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas.

Authors:  Y Komohara; K Ohnishi; J Kuratsu; M Takeya
Journal:  J Pathol       Date:  2008-09       Impact factor: 7.996

9.  A transposon-based genetic screen in mice identifies genes altered in colorectal cancer.

Authors:  Timothy K Starr; Raha Allaei; Kevin A T Silverstein; Rodney A Staggs; Aaron L Sarver; Tracy L Bergemann; Mihir Gupta; M Gerard O'Sullivan; Ilze Matise; Adam J Dupuy; Lara S Collier; Scott Powers; Ann L Oberg; Yan W Asmann; Stephen N Thibodeau; Lino Tessarollo; Neal G Copeland; Nancy A Jenkins; Robert T Cormier; David A Largaespada
Journal:  Science       Date:  2009-02-26       Impact factor: 47.728

10.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways.

Authors: 
Journal:  Nature       Date:  2008-09-04       Impact factor: 49.962

View more
  31 in total

Review 1.  Review: In vivo models for defining molecular subtypes of the primitive neuroectodermal tumor genome: current challenges and solutions.

Authors:  Jon D Larson; David A Largaespada
Journal:  In Vivo       Date:  2012 Jul-Aug       Impact factor: 2.155

Review 2.  In vivo functional screening for systems-level integrative cancer genomics.

Authors:  Julia Weber; Christian J Braun; Dieter Saur; Roland Rad
Journal:  Nat Rev Cancer       Date:  2020-07-07       Impact factor: 60.716

3.  CSF1 overexpression has pleiotropic effects on microglia in vivo.

Authors:  Ishani De; Maria Nikodemova; Megan D Steffen; Emily Sokn; Vilena I Maklakova; Jyoti J Watters; Lara S Collier
Journal:  Glia       Date:  2014-07-05       Impact factor: 7.452

4.  CSF1 Overexpression Promotes High-Grade Glioma Formation without Impacting the Polarization Status of Glioma-Associated Microglia and Macrophages.

Authors:  Ishani De; Megan D Steffen; Paul A Clark; Clayton J Patros; Emily Sokn; Stephanie M Bishop; Suzanne Litscher; Vilena I Maklakova; John S Kuo; Fausto J Rodriguez; Lara S Collier
Journal:  Cancer Res       Date:  2016-03-24       Impact factor: 12.701

5.  Selective depletion of cultured macrophages by magnetite nanoparticles modified with gelatin.

Authors:  Yoshihiro Komohara; Ryuta Kawauchi; Erika Makiyama; Kazuki Mikami; Hasita Horlad; Yukio Fujiwara; Tetsuya Kida; Motohiro Takeya; Takuro Niidome
Journal:  Exp Ther Med       Date:  2017-06-21       Impact factor: 2.447

6.  Microglial stimulation of glioblastoma invasion involves epidermal growth factor receptor (EGFR) and colony stimulating factor 1 receptor (CSF-1R) signaling.

Authors:  Salvatore J Coniglio; Eliseo Eugenin; Kostantin Dobrenis; E Richard Stanley; Brian L West; Marc H Symons; Jeffrey E Segall
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

7.  Glioblastoma-derived Macrophage Colony-stimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-binding Protein 1 (IGFBP1) to Promote Angiogenesis.

Authors:  Mamatha Bangalore Nijaguna; Vikas Patil; Serge Urbach; Shivayogi D Shwetha; Kotha Sravani; Alangar S Hegde; Bangalore A Chandramouli; Arimappamagan Arivazhagan; Philippe Marin; Vani Santosh; Kumaravel Somasundaram
Journal:  J Biol Chem       Date:  2015-08-05       Impact factor: 5.157

Review 8.  What underlies the diversity of brain tumors?

Authors:  Fredrik J Swartling; Sanna-Maria Hede; William A Weiss
Journal:  Cancer Metastasis Rev       Date:  2013-06       Impact factor: 9.264

Review 9.  Pre-clinical tumor models of primary brain tumors: Challenges and opportunities.

Authors:  Farhana Akter; Brennan Simon; Nadine Leonie de Boer; Navid Redjal; Hiroaki Wakimoto; Khalid Shah
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-10-23       Impact factor: 10.680

10.  Targeting CSF1R Alone or in Combination with PD1 in Experimental Glioma.

Authors:  Justyna M Przystal; Hannes Becker; Denis Canjuga; Foteini Tsiami; Nicole Anderle; Anna-Lena Keller; Anja Pohl; Carola H Ries; Martina Schmittnaegel; Nataliya Korinetska; Marilin Koch; Jens Schittenhelm; Marcos Tatagiba; Christian Schmees; Susanne C Beck; Ghazaleh Tabatabai
Journal:  Cancers (Basel)       Date:  2021-05-15       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.